⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
LALPATHLAB - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.6
| Stock Code | LALPATHLAB | Market Cap | 25,760 Cr. | Current Price | 1,537 ₹ | High / Low | 1,771 ₹ |
| Stock P/E | 48.5 | Book Value | 148 ₹ | Dividend Yield | 0.78 % | ROCE | 29.4 % |
| ROE | 23.1 % | Face Value | 10.0 ₹ | DMA 50 | 1,406 ₹ | DMA 200 | 1,445 ₹ |
| Chg in FII Hold | -3.11 % | Chg in DII Hold | 2.17 % | PAT Qtr | 141 Cr. | PAT Prev Qtr | 113 Cr. |
| RSI | 64.6 | MACD | 29.2 | Volume | 7,19,575 | Avg Vol 1Wk | 24,85,392 |
| Low price | 1,272 ₹ | High price | 1,771 ₹ | PEG Ratio | 2.18 | Debt to equity | 0.08 |
| 52w Index | 53.0 % | Qtr Profit Var | -4.92 % | EPS | 30.3 ₹ | Industry PE | 34.1 |
📊 LALPATHLAB presents moderate potential for intraday trading. The stock is trading above both DMA 50 and DMA 200, which indicates near-term support. RSI at 64.6 suggests momentum is leaning toward overbought but not extreme. MACD remains positive, though volume is significantly below the 1-week average, reducing conviction for strong intraday moves.
- 💰 Optimal Buy Price: Around 1,520 ₹ (near support zone)
- 📈 Profit-Taking Exit Levels: 1,555 ₹ – 1,575 ₹ (short-term resistance)
- 📉 Stop-Loss / Loss Protection: 1,500 ₹ (below DMA 50 support)
- ⏱️ If Already Holding: Exit if price fails to sustain above 1,540 ₹ or if RSI crosses 65 with declining volume.
Positive
- Strong ROCE (29.4%) and ROE (23.1%) indicate efficient capital use
- Dividend yield of 0.78% provides shareholder return
- PAT improved from 113 Cr. to 141 Cr. in the latest quarter
- Stock trading above DMA 50 and DMA 200, showing technical strength
Limitation
- P/E ratio (48.5) is higher than industry average (34.1)
- Quarterly profit variation negative (-4.92%), showing inconsistency
- Volume significantly below 1-week average, limiting intraday momentum
- PEG ratio at 2.18, suggesting valuation concerns
Company Negative News
- FII holdings decreased (-3.11%)
- Quarterly profit variation shows decline despite PAT improvement
Company Positive News
- DII holdings increased (+2.17%), showing domestic institutional confidence
- EPS at 30.3 ₹ reflects solid earnings base
- Stock trading near 52-week high (53% gain from low)
Industry
- Diagnostics industry P/E at 34.1, showing sector growth
- Healthcare demand remains strong with rising preventive testing trends
Conclusion
⚖️ LALPATHLAB is a moderately good candidate for intraday trading with strong fundamentals and technical support. However, high valuation and weak volume participation limit upside potential. Traders may consider entries near 1,520 ₹ with tight stop-losses and exit around 1,555–1,575 ₹. If already holding, monitor momentum closely and exit if price weakens below 1,500 ₹.